Neuburgh Advisers’s Medicines Co MDCO Stock Holding History

Neuburgh Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$563K	Buy	11,264 +528	+5%	+$21.1K	0.02%	433
2019 Q2	$391K	Buy	10,736 +308	+3%	+$10.1K	0.01%	518
2019 Q1	$292K	Hold	10,428	–	–	0.01%	584
2018 Q4	$200K	Buy	10,428 +2,354	+29%	+$54.8K	0.01%	635
2018 Q3	$242K	Buy	8,074 +1,628	+25%	+$61.3K	0.01%	659
2018 Q2	$236K	Buy	6,446 +286	+5%	+$9.29K	0.01%	612
2018 Q1	$203K	Hold	6,160	–	–	0.01%	634
2017 Q4	$168K	Buy	6,160 +880	+17%	+$27.1K	0.01%	696
2017 Q3	$196K	Buy	5,280 +726	+16%	+$26.8K	0.01%	610
2017 Q2	$173K	Buy	4,554 +1,958	+75%	+$87.2K	0.01%	610
2017 Q1	$127K	Buy	2,596 +286	+12%	+$13K	0.01%	579
2016 Q4	$78K	Buy	+2,310	New	+$81.9K	﹤0.01%	651

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Neuburgh Advisers's MDCO Position: Q3 2019 in Review

Neuburgh Advisers increased its Medicines Co (MDCO) stake by 4.9% in Q3 2019, buying an estimated $21.1K and bringing the position to 11,264 shares worth $563K. The position accounts for 0.02% of the portfolio, ranked #433.

Neuburgh Advisers first reported a position in MDCO in Q4 2016 and has held it in 12 quarters since. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

Neuburgh Advisers held 11,264 shares of Medicines Co worth $563K as of Q3 2019.
Neuburgh Advisers bought 528 Medicines Co shares in Q3 2019, an estimated $21.1K.
Medicines Co made up 0.02% of Neuburgh Advisers's portfolio in Q3 2019, its #433 holding.
Neuburgh Advisers first reported a position in Medicines Co in Q4 2016 and has held it in 12 quarters since.
250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.